Use of genome-wide association studies for drug repositioning (original) (raw)
- Correspondence
- Published: 10 April 2012
- Pankaj Agarwal1,
- Michael R Barnes1 nAff5,
- Tomi Pastinen2,
- J Brent Richards3,
- Lon R Cardon4 &
- …
- Vincent Mooser4 nAff5
Nature Biotechnology volume 30, pages 317–320 (2012)Cite this article
- 9332 Accesses
- 278 Citations
- 22 Altmetric
- Metrics details
Subjects
To the Editor:
Over the past few years, large investments have been made in genome-wide association studies (GWAS) with the expectation that some of these studies would lead to the identification of novel therapeutic modalities or allow selection of patients who would respond better to therapeutic interventions. Although the results have provided valuable biological insights for many common diseases, the translation of the genetics findings from GWAS into the clinic remains limited and a topic of intense debate. Among the factors that could explain this situation are that the road from a gene target to an approved marketed drug takes in general more than ten years and most GWAS results have only been obtained over the past four years. Furthermore, because the effect size of the common variants identified by GWAS, alone or in aggregation, is generally modest, the impact in terms of personalized, individually tailored medicine has been negligible. We present here an analysis of another potential application of GWAS data—drug repositioning. In the following study, we assess the utility of GWAS in systematically and rapidly identifying alternative or refined indications for existing drugs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Drug repurposing: a systematic review on root causes, barriers and facilitators
- Nithya Krishnamurthy
- , Alyssa A. Grimshaw
- … Jennifer E. Miller
BMC Health Services Research Open Access 29 July 2022
Considerations and challenges for sex-aware drug repurposing
- Jennifer L. Fisher
- , Emma F. Jones
- … Brittany N. Lasseigne
Biology of Sex Differences Open Access 25 March 2022
The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
- Santiago G. Lago
- & Sabine Bahn
npj Genomic Medicine Open Access 25 March 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Figure 1: Analysis pipeline.
References
- Kathiresan, S. et al. Nat. Genet. 40, 189–197 (2008).
Article CAS Google Scholar - Franke, A. et al. Nat. Genet. 42, 1118–1125 (2010).
Article CAS Google Scholar - Moschen, A.R. et al. Gut 54, 479–487 (2005).
Article CAS Google Scholar - Stefansson, H. et al. Nat. Genet. 41, 277–279 (2009).
Article CAS Google Scholar - Clark, L.N. et al. Eur. J. Hum. Genet. 18, 838–843 (2010).
Article CAS Google Scholar - Louis, E.D. Lancet Neurol. 4, 100–110 (2005).
Article Google Scholar - Tobacco and Genetics Consortium. Nat. Genet. 42, 441–447 (2010).
- Stuart, P.E. et al. Nat. Genet. 42, 1000–1004 (2010).
Article CAS Google Scholar - Ormerod, A.D. et al. Arch. Dermatol. Res. 290, 3–8 (1998).
Article CAS Google Scholar - Ormerod, A.D. et al. Br. J. Dermatol. 142, 985–990 (2000).
Article CAS Google Scholar - Welsh, P. et al. J. Clin. Endocrinol. Metab. 95, 93–99 (2010).
Article CAS Google Scholar - Xu, K. & Coté, T.R. Brief. Bioinform. 12, 341–345 (2011).
Article CAS Google Scholar - Nair, R.P. et al. Nat. Genet. 41, 199–204 (2009).
Article CAS Google Scholar - Styrkarsdottir, U. et al. Nat. Genet. 41, 15–17 (2009).
Article CAS Google Scholar - Zeggini, E. et al. Science 316, 1336–1341 (2007).
Article CAS Google Scholar - Imielinski, M. et al. Nat. Genet. 41, 1335–1340 (2009).
Article CAS Google Scholar - Barrett, J.C. et al. Nat. Genet. 40, 955–962 (2008).
Article CAS Google Scholar - Anderson, C.A. et al. Nat. Genet. 43, 246–252 (2011).
Article CAS Google Scholar - Dubois, P.C. et al. Nat. Genet. 42, 295–302 (2010).
Article CAS Google Scholar - Baratz, K.H. et al. N. Engl. J. Med. 363, 1016–1024 (2010).
Article CAS Google Scholar
Acknowledgements
The authors thank K. Peters for helpful comments on this manuscript. T.P. holds a Canada Research Chair and is supported by the Canadian Institutes of Health Research (CIHR). J.B.R. is supported by the CIHR, Ministere Développement Economique, Innovation et Exportation du Québec, Fonds de la Recherche en Santé du Québec, Lady Davis Institute of Medical Research.
Author information
Author notes
- Michael R Barnes & Vincent Mooser
Present address: Present addresses: William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK and Department of Pathology and Laboratory Medicine, CHUV University Hospital, Lausanne, Switzerland.,
Authors and Affiliations
- Computational Biology Department, Quantitative Sciences, GlaxoSmithKline, Stevenage, UK
Philippe Sanseau, Pankaj Agarwal & Michael R Barnes - Departments of Human and Medical Genetics, McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada
Tomi Pastinen - Departments of Medicine, Human Genetics, Epidemiology and Biostatistics, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
J Brent Richards - Genetics Department, Quantitative Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania, USA
Lon R Cardon & Vincent Mooser
Authors
- Philippe Sanseau
You can also search for this author inPubMed Google Scholar - Pankaj Agarwal
You can also search for this author inPubMed Google Scholar - Michael R Barnes
You can also search for this author inPubMed Google Scholar - Tomi Pastinen
You can also search for this author inPubMed Google Scholar - J Brent Richards
You can also search for this author inPubMed Google Scholar - Lon R Cardon
You can also search for this author inPubMed Google Scholar - Vincent Mooser
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toPhilippe Sanseau.
Ethics declarations
Competing interests
P.X.S. is a full-time employee of GlaxoSmithKline, a pharmaceutical company.
Supplementary information
Rights and permissions
About this article
Cite this article
Sanseau, P., Agarwal, P., Barnes, M. et al. Use of genome-wide association studies for drug repositioning.Nat Biotechnol 30, 317–320 (2012). https://doi.org/10.1038/nbt.2151
- Published: 10 April 2012
- Issue Date: April 2012
- DOI: https://doi.org/10.1038/nbt.2151